Case Study: Cross-Strait Agreement Could Shorten IND Timeframe For Products Entering China (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Global pharmaceutical firms can look no further than across the Taiwan Strait when working to get products approved and launched in China faster.